STK11 (Serine/threonine kinase 11) ou LKB1 é uma proteína tipo quinase codificada nos humanos pelo gene STK11.[1]
Referências
↑Jenne DE, Reimann H, Nezu J, Friedel W, Loff S, Jeschke R, Müller O, Back W, Zimmer M (1998). «Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase». Nature genetics. 18 (1): 38–43. PMID9425897. doi:10.1038/ng0198-38 !CS1 manut: Nomes múltiplos: lista de autores (link)
Yoo LI, Chung DC, Yuan J (2002). «LKB1--a master tumour suppressor of the small intestine and beyond.». Nat. Rev. Cancer. 2 (7): 529–35. PMID12094239. doi:10.1038/nrc843 !CS1 manut: Nomes múltiplos: lista de autores (link)
Baas AF, Smit L, Clevers H (2004). «LKB1 tumor suppressor protein: PARtaker in cell polarity.». Trends Cell Biol. 14 (6): 312–9. PMID15183188. doi:10.1016/j.tcb.2004.04.001 !CS1 manut: Nomes múltiplos: lista de autores (link)
Katajisto P, Vallenius T, Vaahtomeri K; et al. (2007). «The LKB1 tumor suppressor kinase in human disease.». Biochim. Biophys. Acta. 1775 (1): 63–75. PMID17010524. doi:10.1016/j.bbcan.2006.08.003 !CS1 manut: Uso explícito de et al. (link) !CS1 manut: Nomes múltiplos: lista de autores (link)
Bonaldo MF, Lennon G, Soares MB (1997). «Normalization and subtraction: two approaches to facilitate gene discovery.». Genome Res. 6 (9): 791–806. PMID8889548. doi:10.1101/gr.6.9.791 !CS1 manut: Nomes múltiplos: lista de autores (link)
Hemminki A, Tomlinson I, Markie D; et al. (1997). «Localization of a susceptibility locus for Peutz-Jeghers syndrome to 19p using comparative genomic hybridization and targeted linkage analysis.». Nat. Genet. 15 (1): 87–90. PMID8988175. doi:10.1038/ng0197-87 !CS1 manut: Uso explícito de et al. (link) !CS1 manut: Nomes múltiplos: lista de autores (link)
Jenne DE, Reimann H, Nezu J; et al. (1998). «Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase.». Nat. Genet. 18 (1): 38–43. PMID9425897. doi:10.1038/ng0198-38 !CS1 manut: Uso explícito de et al. (link) !CS1 manut: Nomes múltiplos: lista de autores (link)
Hemminki A, Markie D, Tomlinson I; et al. (1998). «A serine/threonine kinase gene defective in Peutz-Jeghers syndrome.». Nature. 391 (6663): 184–7. PMID9428765. doi:10.1038/34432 !CS1 manut: Uso explícito de et al. (link) !CS1 manut: Nomes múltiplos: lista de autores (link)
Bignell GR, Barfoot R, Seal S; et al. (1998). «Low frequency of somatic mutations in the LKB1/Peutz-Jeghers syndrome gene in sporadic breast cancer.». Cancer Res. 58 (7): 1384–6. PMID9537235 !CS1 manut: Uso explícito de et al. (link) !CS1 manut: Nomes múltiplos: lista de autores (link)
Nakagawa H, Koyama K, Miyoshi Y; et al. (1998). «Nine novel germline mutations of STK11 in ten families with Peutz-Jeghers syndrome.». Hum. Genet. 103 (2): 168–72. PMID9760200. doi:10.1007/s004390050801 !CS1 manut: Uso explícito de et al. (link) !CS1 manut: Nomes múltiplos: lista de autores (link)
Guldberg P, thor Straten P, Ahrenkiel V; et al. (1999). «Somatic mutation of the Peutz-Jeghers syndrome gene, LKB1/STK11, in malignant melanoma.». Oncogene. 18 (9): 1777–80. PMID10208439. doi:10.1038/sj.onc.1202486 !CS1 manut: Uso explícito de et al. (link) !CS1 manut: Nomes múltiplos: lista de autores (link)
Scanlan MJ, Gordan JD, Williamson B; et al. (1999). «Antigens recognized by autologous antibody in patients with renal-cell carcinoma.». Int. J. Cancer. 83 (4): 456–64. PMID10508479. doi:10.1002/(SICI)1097-0215(19991112)83:4<456::AID-IJC4>3.0.CO;2-5 !CS1 manut: Uso explícito de et al. (link) !CS1 manut: Nomes múltiplos: lista de autores (link)
Sapkota GP, Kieloch A, Lizcano JM; et al. (2001). «Phosphorylation of the protein kinase mutated in Peutz-Jeghers cancer syndrome, LKB1/STK11, at Ser431 by p90(RSK) and cAMP-dependent protein kinase, but not its farnesylation at Cys(433), is essential for LKB1 to suppress cell vrowth.». J. Biol. Chem. 276 (22): 19469–82. PMID11297520. doi:10.1074/jbc.M009953200 !CS1 manut: Uso explícito de et al. (link) !CS1 manut: Nomes múltiplos: lista de autores (link)
Karuman P, Gozani O, Odze RD; et al. (2001). «The Peutz-Jegher gene product LKB1 is a mediator of p53-dependent cell death.». Mol. Cell. 7 (6): 1307–19. PMID11430832. doi:10.1016/S1097-2765(01)00258-1 !CS1 manut: Uso explícito de et al. (link) !CS1 manut: Nomes múltiplos: lista de autores (link)
Marignani PA, Kanai F, Carpenter CL (2001). «LKB1 associates with Brg1 and is necessary for Brg1-induced growth arrest.». J. Biol. Chem. 276 (35): 32415–8. PMID11445556. doi:10.1074/jbc.C100207200 !CS1 manut: Nomes múltiplos: lista de autores (link)
Sanchez-Cespedes M, Parrella P, Esteller M, Nomoto S, Trink B, Engles JM, Westra WH, Herman JG, Sidransky D (2002). «Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lung.». Cancer Res. 62 (13): 3659–62. PMID12097271 !CS1 manut: Nomes múltiplos: lista de autores (link)
Abed AA, Günther K, Kraus C; et al. (2002). «Mutation screening at the RNA level of the STK11/LKB1 gene in Peutz-Jeghers syndrome reveals complex splicing abnormalities and a novel mRNA isoform (STK11 c.597(insertion mark)598insIVS4).». Hum. Mutat. 18 (5): 397–410. PMID11668633. doi:10.1002/humu.1211 !CS1 manut: Uso explícito de et al. (link) !CS1 manut: Nomes múltiplos: lista de autores (link)